Current Signal Transduction Therapy
Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
  |
Most Accessed Articles
Bladder Cancer and Stem Cells
, 2012; 7(3): 209-219.Tomasz Drewa, Sandra Krzyzanowska, Andrzej Marszalek and Anna Bajek
DOI: 10.2174/157436212802481556
Astrocytic Signaling in Persistent Pain
, 2012; 7(1): 56-74.Yu-Xia Chu, Zhi-Qi Zhao and Feng Wei
DOI: 10.2174/157436212799278052
Overview of Mechanisms of Cancer Stem Cell Drug Resistance
, 2013; 8(3): 180-192.Bozena Kaminska, Dorota Weronika Kulesza and Kavita Ramji
DOI: 10.2174/1574362409666140206221621
Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets
, 2013; 8(3): 203-209.Anna M. Czarnecka and Cezary Szczylik
DOI: 10.2174/1574362409666140206222251
Current Biomarkers for Lung Cancer
, 2014; 9(3): 123-128.Kaifei Wang, Zhaohui Huang, Ruilin Wang, Jin Qian, Zhenhua Zuo, Yaping Li, Xiaoyan Yao and Xizhou Guan
DOI: 10.2174/1574362409666140911225531
Optimization of the Enzymolysis Conditions for Scorpion Peptides and Evaluation of its Antitumor Activity
, 2016; 11(1): 41-48.Fangwen Jiao, Jihui Wang, Yuhong Liu, Yan Zou, Wei Jia, Panpan Zhang, Jing Sun, Youwei Xu and Junxiang Wang
DOI: 10.2174/1574362411666160517113916
Astrocyte Signaling and Multiple Sclerosis
, 2012; 7(1): 14-19.Miguel D'haeseleer, Melissa Cambron and Jacques De Keyser
DOI: 10.2174/157436212799278133
Signal Transduction Therapy in Pancreatic Cancer
, 2014; 9(2): 78-82.Xiaotian Sun, Zhaoshen Li and Min Li
DOI: 10.2174/1574362409666141201205149
Role of Fibroblast Growth Factor Receptors in Astrocytic Stem Cells
, 2012; 7(1): 81-86.Alma Y. Galvez-Contreras, Rocio E. Gonzalez-Castaneda, Sonia Luquin and Oscar Gonzalez-Perez
DOI: 10.2174/157436212799278205
Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases
, 2011; 6(1): 29-43.Ota Fuchs
DOI: 10.2174/157436211794109398
Editor-in-Chief
Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
View Full Editorial Board
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net